# SAFINAMIDE
> **ANDA216020** · Abbreviated New Drug Application (Generic) · Sponsor: OPTIMUS PHARMA PRIVATE LTD · Approved 2023-01-12
## Drug
- **FDA Application Number:** ANDA216020
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SAFINAMIDE
- **Generic name:** Safinamide
- **Active ingredients:** SAFINAMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** OPTIMUS PHARMA PRIVATE LTD
- **First approval:** 2023-01-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216020)
---
*AI Analytics · CC0 1.0*